ArticleExploratory research in clinical and social pharmacy2021

Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis.

Jagadeswara Rao Earla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.